Stacey received her Ph.D. in Pharmacology from the University of Washington, where she studied mitochondrial signaling in metastatic breast cancer. Her professional background bridges cancer research and science communication – experience that enables her to evaluate complex therapeutic areas and extract key developments, providing her clients with valuable insight.